SIMILAR PATTERNS OF AMINO ACIDS FOR 6EXI_C_ADNC502_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1tj7 | ARGININOSUCCINATELYASE (Escherichiacoli) |
PF00206(Lyase_1)PF14698(ASL_C2) | 5 | LEU A 103HIS A 104ASP A 33LEU A 3HIS A 85 | None | 1.43A | 6exiC-1tj7A:undetectable | 6exiC-1tj7A:12.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1v8b | ADENOSYLHOMOCYSTEINASE (Plasmodiumfalciparum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 53HIS A 54THR A 56ASP A 234ASN A 391LEU A 392HIS A 398MET A 403 | NoneADN A 502 (-4.1A)ADN A 502 (-3.0A)ADN A 502 (-2.8A)NAD A 501 (-3.0A)ADN A 502 ( 4.9A)ADN A 502 ( 3.5A)ADN A 502 (-3.6A) | 0.31A | 6exiC-1v8bA:55.8 | 6exiC-1v8bA:11.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2gj4 | GLYCOGENPHOSPHORYLASE,MUSCLE FORM (Oryctolaguscuniculus) |
PF00343(Phosphorylase) | 5 | THR A 671THR A 668ASN A 284LEU A 380HIS A 571 | None | 1.15A | 6exiC-2gj4A:4.9 | 6exiC-2gj4A:7.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2hxv | DIAMINOHYDROXYPHOSPHORIBOSYLAMINOPYRIMIDINE DEAMINASE/5-AMINO-6-(5-PHOSPHORIBOSYLAMINO)URACILREDUCTASE (Thermotogamaritima) |
PF00383(dCMP_cyt_deam_1)PF01872(RibD_C) | 5 | HIS A 49ASP A 104ASN A 106HIS A 79ASN A 23 | ZN A 500 (-3.2A)NoneNoneNoneNone | 1.34A | 6exiC-2hxvA:undetectable | 6exiC-2hxvA:16.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2nux | 2-KETO-3-DEOXYGLUCONATE/2-KETO-3-DEOXY-6-PHOSPHO GLUCONATEALDOLASE (Sulfolobusacidocaldarius) |
PF00701(DHDPS) | 5 | LEU A 68THR A 65ASN A 198LEU A 22HIS A 25 | None | 1.33A | 6exiC-2nuxA:undetectable | 6exiC-2nuxA:16.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2xhg | TYROCIDINESYNTHETASE A (Brevibacillusbrevis) |
PF00668(Condensation) | 5 | GLN A 39THR A 392ASN A 412ASN A 368LEU A 370 | NoneNoneNone NA A1469 ( 4.9A)None | 1.49A | 6exiC-2xhgA:undetectable | 6exiC-2xhgA:11.61 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 68GLN A 73THR A 74ASP A 252ASN A 253MET A 421 | NoneADN A 500 (-3.6A)ADN A 500 (-4.5A)ADN A 500 (-2.7A)NAD A 550 (-3.5A)ADN A 500 (-3.7A) | 0.83A | 6exiC-3ce6A:56.8 | 6exiC-3ce6A:60.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 68HIS A 69THR A 71GLN A 73THR A 74ASP A 252ASN A 409LEU A 410HIS A 416MET A 421 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.6A)ADN A 500 (-4.5A)ADN A 500 (-2.7A)NAD A 550 (-3.0A)ADN A 500 ( 4.8A)ADN A 500 ( 3.6A)ADN A 500 (-3.7A) | 0.27A | 6exiC-3ce6A:56.8 | 6exiC-3ce6A:60.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ce6 | ADENOSYLHOMOCYSTEINASE (Mycobacteriumtuberculosis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 68HIS A 69THR A 71GLN A 73THR A 74HIS A 363LEU A 410 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A)ADN A 500 (-3.6A)ADN A 500 (-4.5A)ADN A 500 ( 3.7A)ADN A 500 ( 4.8A) | 0.99A | 6exiC-3ce6A:56.8 | 6exiC-3ce6A:60.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3d6n | DIHYDROOROTASE (Aquifexaeolicus) |
PF01979(Amidohydro_1) | 5 | THR A 124ASP A 305HIS A 180ASN A 95HIS A 63 | NoneFLC A 424 ( 2.7A)FLC A 424 (-4.0A)FLC A 424 (-3.6A) ZN A 423 ( 3.4A) | 1.27A | 6exiC-3d6nA:undetectable | 6exiC-3d6nA:15.70 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 52THR A 54ASN A 190LEU A 343HIS A 352 | ADN A 438 (-4.0A)ADN A 438 (-2.8A)NAD A 439 (-3.2A)NAD A 439 ( 4.0A)ADN A 438 ( 3.6A) | 1.38A | 6exiC-3g1uA:54.1 | 6exiC-3g1uA:71.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 51HIS A 52THR A 54GLN A 56THR A 57ASN A 190ASN A 345LEU A 346HIS A 352MET A 357 | NoneADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-3.8A)ADN A 438 (-4.6A)NAD A 439 (-3.2A)NAD A 439 (-3.1A)ADN A 438 ( 4.8A)ADN A 438 ( 3.6A)ADN A 438 (-3.7A) | 0.51A | 6exiC-3g1uA:54.1 | 6exiC-3g1uA:71.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3g1u | ADENOSYLHOMOCYSTEINASE (Leishmaniamajor) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 51HIS A 52THR A 54GLN A 56THR A 57HIS A 300LEU A 346 | NoneADN A 438 (-4.0A)ADN A 438 (-2.8A)ADN A 438 (-3.8A)ADN A 438 (-4.6A)ADN A 438 ( 4.0A)ADN A 438 ( 4.8A) | 1.02A | 6exiC-3g1uA:54.1 | 6exiC-3g1uA:71.62 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62THR A 64ASP A 233ASN A 234LEU A 385 | RAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-2.5A)NAD A 601 (-3.5A)NAD A 601 ( 4.1A) | 1.24A | 6exiC-3glqA:60.3 | 6exiC-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LEU A 61HIS A 62ASP A 233ASN A 234LEU A 385 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.5A)NAD A 601 (-3.5A)NAD A 601 ( 4.1A) | 1.32A | 6exiC-3glqA:60.3 | 6exiC-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67ASP A 233ASN A 234MET A 399 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-2.5A)NAD A 601 (-3.5A)RAB A 602 (-3.6A) | 0.80A | 6exiC-3glqA:60.3 | 6exiC-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67ASP A 233ASN A 387LEU A 388HIS A 394MET A 399 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 (-2.5A)NAD A 601 (-3.0A)RAB A 602 ( 4.7A)NAD A 601 ( 3.6A)RAB A 602 (-3.6A) | 0.28A | 6exiC-3glqA:60.3 | 6exiC-3glqA:61.11 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3glq | ADENOSYLHOMOCYSTEINASE (Burkholderiapseudomallei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67HIS A 344LEU A 388 | NoneRAB A 602 (-3.8A)RAB A 602 (-2.7A)RAB A 602 (-3.9A)RAB A 602 (-4.5A)RAB A 602 ( 3.5A)RAB A 602 ( 4.7A) | 0.98A | 6exiC-3glqA:60.3 | 6exiC-3glqA:61.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 51HIS A 52THR A 54GLN A 56THR A 57ASP A 189ASN A 345LEU A 346HIS A 352MET A 357 | NoneADN A 439 ( 4.7A)ADN A 439 (-2.7A)ADN A 439 (-3.6A)ADN A 439 (-4.7A)NAD A 438 ( 4.4A)NAD A 438 (-2.9A)ADN A 439 ( 4.7A)ADN A 439 ( 3.3A)ADN A 439 ( 3.7A) | 0.30A | 6exiC-3h9uA:56.4 | 6exiC-3h9uA:13.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 51HIS A 52THR A 54GLN A 56THR A 57HIS A 300LEU A 346 | NoneADN A 439 ( 4.7A)ADN A 439 (-2.7A)ADN A 439 (-3.6A)ADN A 439 (-4.7A)NoneADN A 439 ( 4.7A) | 1.02A | 6exiC-3h9uA:56.4 | 6exiC-3h9uA:13.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3h9u | ADENOSYLHOMOCYSTEINASE (Trypanosomabrucei) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 51THR A 54GLN A 56THR A 57ASP A 189ASN A 190MET A 357 | NoneADN A 439 (-2.7A)ADN A 439 (-3.6A)ADN A 439 (-4.7A)NAD A 438 ( 4.4A)NAD A 438 (-3.4A)ADN A 439 ( 3.7A) | 0.83A | 6exiC-3h9uA:56.4 | 6exiC-3h9uA:13.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3hdi | PROCESSING PROTEASE (Bacillushalodurans) |
PF00675(Peptidase_M16)PF05193(Peptidase_M16_C) | 5 | LEU A 269THR A 318GLN A 315THR A 317LEU A 239 | None | 1.46A | 6exiC-3hdiA:undetectable | 6exiC-3hdiA:12.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 54GLN A 59THR A 60ASP A 226ASN A 227MET A 392 | None K A 2 ( 3.3A)ADN A 500 (-4.6A)ADN A 500 ( 2.6A)NAD A 550 (-3.6A)ADN A 500 (-3.7A) | 0.91A | 6exiC-3n58A:32.3 | 6exiC-3n58A:14.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 54HIS A 55THR A 57GLN A 59THR A 60ASP A 226ASN A 380LEU A 381HIS A 387MET A 392 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A) K A 2 ( 3.3A)ADN A 500 (-4.6A)ADN A 500 ( 2.6A)NAD A 550 (-3.0A)ADN A 500 ( 4.8A)ADN A 500 (-3.4A)ADN A 500 (-3.7A) | 0.26A | 6exiC-3n58A:32.3 | 6exiC-3n58A:14.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3n58 | ADENOSYLHOMOCYSTEINASE (Brucellaabortus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 54HIS A 55THR A 57GLN A 59THR A 60HIS A 337LEU A 381 | NoneADN A 500 (-4.0A)ADN A 500 (-2.8A) K A 2 ( 3.3A)ADN A 500 (-4.6A)ADN A 500 ( 3.6A)ADN A 500 ( 4.8A) | 1.00A | 6exiC-3n58A:32.3 | 6exiC-3n58A:14.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | HIS A 62THR A 64ASP A 239ASN A 240LEU A 395 | ADE A 506 (-4.6A)ADE A 506 (-2.8A)NAD A 501 ( 4.5A)NAD A 501 (-3.5A)NAD A 501 (-4.2A) | 1.26A | 6exiC-3oneA:56.5 | 6exiC-3oneA:64.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 8 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67ASP A 239ASN A 240MET A 409 | NoneADE A 506 (-4.6A)ADE A 506 (-2.8A)ADE A 506 (-3.8A)ADE A 506 (-4.5A)NAD A 501 ( 4.5A)NAD A 501 (-3.5A)ADE A 506 (-3.8A) | 0.93A | 6exiC-3oneA:56.5 | 6exiC-3oneA:64.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67ASP A 239ASN A 397LEU A 398HIS A 404MET A 409 | NoneADE A 506 (-4.6A)ADE A 506 (-2.8A)ADE A 506 (-3.8A)ADE A 506 (-4.5A)NAD A 501 ( 4.5A)NAD A 501 (-3.0A)ADE A 506 ( 4.7A)ADE A 506 (-3.4A)ADE A 506 (-3.8A) | 0.53A | 6exiC-3oneA:56.5 | 6exiC-3oneA:64.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3one | ADENOSYLHOMOCYSTEINASE (Lupinus luteus) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 61HIS A 62THR A 64GLN A 66THR A 67HIS A 350LEU A 398 | NoneADE A 506 (-4.6A)ADE A 506 (-2.8A)ADE A 506 (-3.8A)ADE A 506 (-4.5A)NoneADE A 506 ( 4.7A) | 1.18A | 6exiC-3oneA:56.5 | 6exiC-3oneA:64.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4dwq | TRNA-SPLICING LIGASERTCB (Pyrococcushorikoshii) |
PF01139(RtcB) | 5 | HIS A 67GLN A 46THR A 43ASN A 330HIS A 404 | POP A 509 (-3.7A)NoneNoneMLI A 503 (-4.1A)5GP A 501 (-3.0A) | 1.49A | 6exiC-4dwqA:undetectable | 6exiC-4dwqA:11.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4f7k | LACCASE (unculturedbacterium) |
PF00394(Cu-oxidase)PF07731(Cu-oxidase_2)PF07732(Cu-oxidase_3) | 5 | HIS A 378GLN A 100THR A 99HIS A 421HIS A 126 | None | 1.41A | 6exiC-4f7kA:undetectable | 6exiC-4f7kA:12.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4j7b | POLO-LIKE KINASE (Danio rerio) |
PF00069(Pkinase) | 5 | LEU A 223THR A 146ASN A 167LEU A 168HIS A 160 | None | 1.32A | 6exiC-4j7bA:undetectable | 6exiC-4j7bA:16.55 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 6 | LEU A 57GLN A 62THR A 63ASP A 231ASN A 232MET A 397 | NoneNH4 A 502 ( 3.1A)ADN A 501 (-4.5A)ADN A 501 (-3.1A)NAD A 503 (-3.6A)ADN A 501 (-3.7A) | 0.90A | 6exiC-4lvcA:64.4 | 6exiC-4lvcA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 57HIS A 58THR A 60GLN A 62THR A 63ASP A 231ASN A 385LEU A 386HIS A 392MET A 397 | NoneADN A 501 (-4.0A)ADN A 501 (-2.8A)NH4 A 502 ( 3.1A)ADN A 501 (-4.5A)ADN A 501 (-3.1A)NAD A 503 (-3.1A)ADN A 501 ( 4.7A)ADN A 501 (-3.5A)ADN A 501 (-3.7A) | 0.29A | 6exiC-4lvcA:64.4 | 6exiC-4lvcA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4lvc | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE(SAHASE) (Bradyrhizobiumelkanii) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57HIS A 58THR A 60GLN A 62THR A 63HIS A 342LEU A 386 | NoneADN A 501 (-4.0A)ADN A 501 (-2.8A)NH4 A 502 ( 3.1A)ADN A 501 (-4.5A)ADN A 501 ( 3.7A)ADN A 501 ( 4.7A) | 1.02A | 6exiC-4lvcA:64.4 | 6exiC-4lvcA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zmh | UNCHARACTERIZEDPROTEIN (Saccharophagusdegradans) |
PF15979(Glyco_hydro_115) | 5 | LEU A 399HIS A 282ASP A 402ASN A 404HIS A 428 | NoneNoneNoneACT A1007 (-3.6A)PO4 A1001 (-3.9A) | 1.39A | 6exiC-4zmhA:undetectable | 6exiC-4zmhA:6.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uq6 | TARTRATE-RESISTANTACID PHOSPHATASETYPE 5 (Sus scrofa) |
PF00149(Metallophos) | 5 | HIS A 195THR A 198ASP A 14ASN A 91HIS A 186 | PO4 A 404 (-3.8A)None FE A 402 ( 3.1A)PO4 A 404 ( 2.6A) FE A 403 ( 3.4A) | 1.27A | 6exiC-5uq6A:undetectable | 6exiC-5uq6A:15.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5uq6 | TARTRATE-RESISTANTACID PHOSPHATASETYPE 5 (Sus scrofa) |
PF00149(Metallophos) | 5 | HIS A 195THR A 198HIS A 223ASN A 91HIS A 186 | PO4 A 404 (-3.8A)None FE A 402 (-3.4A)PO4 A 404 ( 2.6A) FE A 403 ( 3.4A) | 1.38A | 6exiC-5uq6A:undetectable | 6exiC-5uq6A:15.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 52HIS A 53THR A 55THR A 58ASP A 245ASN A 403LEU A 404HIS A 410MET A 415 | NoneSAH A 502 (-4.0A)SAH A 502 (-2.7A)SAH A 502 (-4.2A)SAH A 502 (-2.8A)NAD A 501 (-2.9A)SAH A 502 ( 4.7A)SAH A 502 ( 3.5A)SAH A 502 (-3.6A) | 0.32A | 6exiC-5utuA:53.6 | 6exiC-5utuA:9.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5utu | ADENOSYLHOMOCYSTEINASE (Cryptosporidiumparvum) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LEU A 52THR A 58ASP A 245ASN A 246MET A 415 | NoneSAH A 502 (-4.2A)SAH A 502 (-2.8A)NAD A 501 (-3.5A)SAH A 502 (-3.6A) | 0.87A | 6exiC-5utuA:53.6 | 6exiC-5utuA:9.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 9 | LEU A 58HIS A 59THR A 61THR A 64ASP A 231ASN A 388LEU A 389HIS A 395MET A 400 | NoneADN A 502 ( 3.9A)ADN A 502 (-2.9A)ADN A 502 (-4.4A)ADN A 502 (-2.8A)NAD A 501 (-3.1A)ADN A 502 ( 4.7A)ADN A 502 ( 3.4A)ADN A 502 (-3.8A) | 0.26A | 6exiC-5v96A:58.0 | 6exiC-5v96A:13.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v96 | S-ADENOSYL-L-HOMOCYSTEINE HYDROLASE (Naegleriafowleri) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LEU A 58THR A 64ASP A 231ASN A 232MET A 400 | NoneADN A 502 (-4.4A)ADN A 502 (-2.8A)NAD A 501 (-3.5A)ADN A 502 (-3.8A) | 0.83A | 6exiC-5v96A:58.0 | 6exiC-5v96A:13.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5vbl | APELINRECEPTOR,RUBREDOXIN,APELIN RECEPTORCHIMERA (Clostridiumpasteurianum;Homo sapiens) |
PF00001(7tm_1)PF00301(Rubredoxin) | 5 | LEU B 120THR B 256ASP B 75ASN B 46LEU B 308 | None | 1.23A | 6exiC-5vblB:undetectable | 6exiC-5vblB:13.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LEU A 54HIS A 55THR A 57THR A 60ASP A 190 | None9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)NoneNAD A 501 (-4.1A) | 0.55A | 6exiC-5w4bA:48.4 | 6exiC-5w4bA:12.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5w4b | ADENOSYLHOMOCYSTEINASE (Homo sapiens) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 5 | LEU A 54HIS A 55THR A 57THR A 60MET A 358 | None9W4 A 502 (-3.7A)9W4 A 502 (-2.9A)None9W4 A 502 (-3.6A) | 0.17A | 6exiC-5w4bA:48.4 | 6exiC-5w4bA:12.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57HIS A 58GLN A 62THR A 63ASP A 195ASN A 196MET A 363 | NoneADN A 501 (-3.9A)ADN A 501 (-3.8A)ADN A 501 (-4.5A)ADN A 501 (-2.7A)NAD A 500 (-3.5A)ADN A 501 (-3.7A) | 0.85A | 6exiC-6aphA:29.4 | 6exiC-6aphA:69.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 10 | LEU A 57HIS A 58THR A 60GLN A 62THR A 63ASP A 195ASN A 351LEU A 352HIS A 358MET A 363 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.8A)ADN A 501 (-4.5A)ADN A 501 (-2.7A)NAD A 500 (-3.1A)ADN A 501 ( 4.8A)ADN A 501 ( 3.5A)ADN A 501 (-3.7A) | 0.24A | 6exiC-6aphA:29.4 | 6exiC-6aphA:69.51 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6aph | ADENOSYLHOMOCYSTEINASE (Elizabethkingiaanophelis) |
PF00670(AdoHcyase_NAD)PF05221(AdoHcyase) | 7 | LEU A 57HIS A 58THR A 60GLN A 62THR A 63HIS A 306LEU A 352 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A)ADN A 501 (-3.8A)ADN A 501 (-4.5A)ADN A 501 ( 3.7A)ADN A 501 ( 4.8A) | 1.02A | 6exiC-6aphA:29.4 | 6exiC-6aphA:69.51 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 7 | HIS B 61THR B 63GLN B 65THR B 66ASP B 198ASN B 199MET B 387 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) K B 504 ( 3.0A)ADN B 502 (-4.6A)ADN B 502 (-2.7A)NAD B 501 (-3.5A)ADN B 502 (-3.7A) | 0.87A | 6exiC-6f3mB:52.4 | 6exiC-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 9 | HIS B 61THR B 63GLN B 65THR B 66ASP B 198ASN B 375LEU B 376HIS B 382MET B 387 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) K B 504 ( 3.0A)ADN B 502 (-4.6A)ADN B 502 (-2.7A)NAD B 501 (-3.0A)ADN B 502 ( 4.8A)ADN B 502 (-3.4A)ADN B 502 (-3.7A) | 0.29A | 6exiC-6f3mB:52.4 | 6exiC-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6f3m | - (-) |
no annotation | 6 | HIS B 61THR B 63GLN B 65THR B 66HIS B 323LEU B 376 | ADN B 502 ( 4.0A)ADN B 502 (-2.8A) K B 504 ( 3.0A)ADN B 502 (-4.6A) ZN B 505 (-3.2A)ADN B 502 ( 4.8A) | 0.97A | 6exiC-6f3mB:52.4 | 6exiC-6f3mB:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6g2j | NADH-UBIQUINONEOXIDOREDUCTASE CHAIN4 (Mus musculus) |
no annotation | 5 | THR M 414GLN M 415THR M 413ASN M 366LEU M 282 | None | 1.40A | 6exiC-6g2jM:undetectable | 6exiC-6g2jM:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 10 | LEU A 55HIS A 56THR A 58GLN A 60THR A 61ASP A 193ASN A 349LEU A 350HIS A 356MET A 361 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A) NA A 503 ( 3.2A)ADN A 501 (-4.6A)ADN A 501 (-2.7A)NAD A 502 (-3.1A)ADN A 501 ( 4.7A)ADN A 501 (-3.4A)ADN A 501 (-3.6A) | 0.21A | 6exiC-6gbnA:30.6 | 6exiC-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 7 | LEU A 55HIS A 56THR A 58GLN A 60THR A 61HIS A 304LEU A 350 | NoneADN A 501 (-3.9A)ADN A 501 (-2.8A) NA A 503 ( 3.2A)ADN A 501 (-4.6A)ADN A 501 ( 3.6A)ADN A 501 ( 4.7A) | 1.00A | 6exiC-6gbnA:30.6 | 6exiC-6gbnA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6gbn | - (-) |
no annotation | 5 | LEU A 55THR A 61ASP A 193ASN A 194MET A 361 | NoneADN A 501 (-4.6A)ADN A 501 (-2.7A)NAD A 502 (-3.5A)ADN A 501 (-3.6A) | 0.83A | 6exiC-6gbnA:30.6 | 6exiC-6gbnA:undetectable |